Novo Nordisk A/S (NONOF)
128.38
+2.12
(+1.68%)
USD |
OTCM |
Apr 23, 15:53
Novo Nordisk Cash from Operations (TTM): 12.91B for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 12.91B |
March 31, 2023 | 11.92B |
December 31, 2022 | 11.18B |
September 30, 2022 | 9.272B |
June 30, 2022 | 9.642B |
March 31, 2022 | 10.49B |
December 31, 2021 | 8.752B |
September 30, 2021 | 9.024B |
June 30, 2021 | 8.815B |
March 31, 2021 | 8.306B |
December 31, 2020 | 7.960B |
September 30, 2020 | 8.949B |
June 30, 2020 | 8.326B |
March 31, 2020 | 6.988B |
December 31, 2019 | 7.015B |
September 30, 2019 | 7.465B |
June 30, 2019 | 6.718B |
March 31, 2019 | 6.953B |
December 31, 2018 | 7.067B |
September 30, 2018 | 6.515B |
June 30, 2018 | 7.081B |
March 31, 2018 | 6.152B |
December 31, 2017 | 6.266B |
September 30, 2017 | 7.162B |
June 30, 2017 | 7.130B |
Date | Value |
---|---|
March 31, 2017 | 7.809B |
December 31, 2016 | 7.181B |
September 30, 2016 | 7.073B |
June 30, 2016 | 6.651B |
March 31, 2016 | 6.179B |
December 31, 2015 | 5.696B |
September 30, 2015 | 5.510B |
June 30, 2015 | 5.793B |
March 31, 2015 | 5.528B |
December 31, 2014 | 5.653B |
September 30, 2014 | 5.301B |
June 30, 2014 | 4.346B |
March 31, 2014 | 4.115B |
December 31, 2013 | 4.619B |
September 30, 2013 | 4.017B |
June 30, 2013 | 4.151B |
March 31, 2013 | 4.102B |
December 31, 2012 | 3.836B |
September 30, 2012 | 4.169B |
June 30, 2012 | 4.332B |
March 31, 2012 | 4.041B |
December 31, 2011 | 3.993B |
September 30, 2011 | 4.241B |
June 30, 2011 | 3.919B |
March 31, 2011 | 3.654B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
6.718B
Minimum
Jun 2019
12.91B
Maximum
Jun 2023
9.043B
Average
8.815B
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
Eli Lilly and Co | 4.240B |
Amgen Inc | 8.471B |
Pfizer Inc | 8.70B |
AstraZeneca PLC | 10.34B |